E-Cigarette Research

The Truth Is Out There

User Tools

Site Tools


tag:organization_position

TAG: organization position

AAPHP Statement re State Regulation of E-cigarettes Document The American Association of Public Health Physicians recommends the following State response to proposed legislation to ban or otherwise restrict the sale and use of nicotine vaporizers (commonly referred to as E-cigarettes or electronic cigarettes).
CAADE Board Resolution on Electronic Cigarettes Web Page CAADE SUPPORTS ELECTRONIC CIGARETTES FOR TOBACCO CESSATION: Watch Father Jack's Testimony at the SB 648 hearing on April 17, 2013
E-cigarettes full of puff as user numbers triple Newspaper Article Press Release: UK Centre for Tobacco and Alcohol Studies
ACSH (2013), Ground-breaking study supports e-cigarettes' superiority over nicotine patches | American Council on Science and Health (ACSH),
Key Nicotine Findings.pdf Report Nicotine vs. tobacco smoke The main adverse effect of nicotine is addiction, which sustains tobacco use. Because most smokers are nicotine-dependent, they continue to expose themselves to toxicants from tobacco. Tobacco, not nicotine, is responsible for most of the adverse health effects.
Nicotine addiction and withdrawal Web Document . . . . Causes, incidence, and risk factors Tobacco is a plant grown for its leaves, which are smoked, chewed, or sniffed for a variety of effects.
Nicotine and Health Blog Post This year, how about making a truly meaningful, life-altering New Year’s resolution? If you’re one of 44 million American smokers, we have one for you: Try separating the smoke from your nicotine fix. Doing so will save your life.
Tobacco harm reduction: How rational public policy could transform a pandemic Journal Article Nicotine, at the dosage levels smokers seek, is a relatively innocuous drug commonly delivered by a highly harmful device, cigarette smoke.
Sweanor, D., P. Alcabes, and E. Drucker (03-2007) 'Tobacco harm reduction: How rational public policy could transform a pandemic', International Journal of Drug Policy, 18: 70–74.